All NIH Funding Opportunities and Notices

• Notice of Change to FOA (RFA-OD-19-013) "Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)"
  (NOT-OD-19-044)
  Office of Research on Women's Health
  

• Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
  (NOT-AG-18-053)
  National Institute on Aging
  

• Notice of Change in Expiration Date of PA-17-278 "HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)"
  (NOT-AI-19-018)
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change in Expiration Date of PA-17-280 "In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)"
  (NOT-AI-19-020)
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change in the Award Project Period section in PA-18-914, "Supplements to Advance Research (STAR) from Projects to Programs"
  (NOT-AR-19-033)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• NCCIH Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01 Announcements
  (NOT-AT-19-011)
  National Center for Complementary and Integrative Health
  

• Notice of Additional Funds Available for PAS-18-624, " Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)"
  (NOT-DA-18-048)
  National Institute on Drug Abuse
  Office of Behavioral and Social Science Research
  

• Notice of Expiration for PA-18-495 Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 Clinical Trial Required)
  (NOT-DK-19-005)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• NIDDK Will Participate in RFA-OD-19-012: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)
  (NOT-DK-19-008)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Change in Key Dates for RFA-ES-18-009 "Maintain and Enrich Resource Infrastructure for Existing Environmental Epidemiology Cohorts (R24 Clinical Trial Not Allowed)"
  (NOT-ES-19-005)
  National Institute of Environmental Health Sciences
  

• AHRQ Notice of Cancellation of PA 17-260 and PA 17-261
  (NOT-HS-19-004)
  Agency for Healthcare Research and Quality
  

• Notice of PA 15-179 and PA 16-420 Cancellation
  (NOT-HS-19-005)
  Agency for Healthcare Research and Quality
  

• Notice of PA Cancellation: PA-15-180
  (NOT-HS-19-006)
  Agency for Healthcare Research and Quality
  

• Human Islet Research Network - Consortium on Modeling Autoimmune Interactions (HIRN-CMAI) (U01 Clinical Trial Not Allowed)
  (RFA-DK-18-013)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  

• Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
  (RFA-EB-18-004)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Science Research
  Application Receipt Date(s): February 22, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)
  (RFA-OD-19-014)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): March 19, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
  

• Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
  (PA-19-111)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
  (PA-19-112)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  (PAR-19-113)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Non-human Primates Facilities to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed)
  (PAR-19-114)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): March 6, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
  (PAS-19-105)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 5, 2019.
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892